NextGen Biomed (XTAE:NXGN) Other Stockholders Equity : ₪6.07 Mil (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed Other Stockholders Equity?

NextGen Biomed's Other Stockholders Equity for the quarter that ended in Jun. 2023 was ₪6.07 Mil.

NextGen Biomed's quarterly Other Stockholders Equity declined from Jun. 2022 (₪6.07 Mil) to Dec. 2022 (₪6.07 Mil) but then stayed the same from Dec. 2022 (₪6.07 Mil) to Jun. 2023 (₪6.07 Mil).

NextGen Biomed's annual Other Stockholders Equity declined from Dec. 2020 (₪9.52 Mil) to Dec. 2021 (₪6.07 Mil) and declined from Dec. 2021 (₪6.07 Mil) to Dec. 2022 (₪6.07 Mil).

NextGen Biomed Other Stockholders Equity Historical Data

The historical data trend for NextGen Biomed's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed Other Stockholders Equity Chart

NextGen Biomed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Stockholders Equity

Get a 7-Day Free Trial

6.07

9.52

6.07

NextGen Biomed Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Stockholders Equity	Get a 7-Day Free Trial													10.14	6.07	6.07	6.07	6.07

NextGen Biomed Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

NextGen Biomed Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NextGen Biomed (XTAE:NXGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101

Website

http://www.nextgen-biomed.com

NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.